Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Celularity Inc Director's Dealing 2022

Mar 15, 2022

34506_dirs_2022-03-15_59b0c4d0-070f-41ee-b488-f945170635b6.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celularity Inc (CELU)
CIK: 0001752828
Period of Report: 2022-03-01

Reporting Person: STARR INTERNATIONAL CO INC (10% Owner)
Reporting Person: Starr International Investments Ltd. (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-03-01 Class A Common Stock X 6640694 $3.50 Acquired 15281389 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2022-03-01 Warrant (Right to Buy) $3.50 X 6640694 Disposed Class A Common Stock (6640694) Indirect

Footnotes

F1: The Issuer's securities are directly owned by Starr International Investments Ltd., a wholly-owned subsidiary of Starr International Company, Inc. By virtue of this relationship, Starr International Company, Inc. may be deemed to directly own such shares disclosed in this form.

F2: The first to occur of: (a) March 16, 2025 or (b) the consummation of a Change of Control (as defined in the applicable warrant agreement) following March 1, 2022.